Markets

INCOME STATEMENT

You can view the income statement for the last 5 years.

Aarey Drugs & Pharmaceuticals Ltd.

Jul 10, 04:01 BSE 85.46 ( -1.74 -2.00%)

Volume421

Prev. Close
87.20

Open Price
85.46

Today's Low / High

85.46 85.46

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

50.40 100.00

Jul 10, 03:15 NSE 82.83( -1.69 -2.00%)

Volume7013

Prev. Close
84.52

Open Price
82.83

Today's Low / High

82.83 82.83

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

50.31 100.00

Standalone

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	472.27	473.94	395.62	418.96	492.68
Total Operating Revenues	472.27	473.94	395.62	418.96	492.68

Other Income	6.10	9.81	6.96	2.73	2.75
Total Revenue	478.37	483.76	402.58	421.69	495.43

EXPENSES
Cost Of Materials Consumed	450.56	0.00	0.00	0.00	0.00
Purchase Of Stock-In Trade	0.00	472.87	387.76	418.98	467.29
Changes In Inventories Of FG,WIP And Stock-In Trade	3.94	-10.80	-5.86	-15.14	4.78
Employee Benefit Expenses	0.76	0.81	0.72	0.81	0.98
Finance Costs	5.00	4.66	4.38	2.87	2.00
Depreciation And Amortisation Expenses	2.85	1.94	1.70	1.57	1.99
Other Expenses	9.83	8.18	8.55	6.58	8.37
Total Expenses	472.95	477.65	397.24	415.68	485.40

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.41	6.10	5.34	6.01	10.03

Profit/Loss Before Tax	5.41	6.10	5.34	6.01	10.03

Tax Expenses-Continued Operations
Current Tax	1.45	1.40	1.32	1.78	2.61
Deferred Tax	0.00	0.17	-0.67	-0.04	-0.11
Tax For Earlier Years	0.00	0.51	0.00	0.50	0.98
Total Tax Expenses	1.45	2.08	0.66	2.24	3.48
Profit/Loss After Tax And Before ExtraOrdinary Items	3.97	4.02	4.68	3.77	6.54

Profit/Loss From Continuing Operations	3.97	4.02	4.68	3.77	6.54

Profit/Loss For The Period	3.97	4.02	4.68	3.77	6.54

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	1.39	1.42	1.67	1.49	2.72
Diluted EPS (Rs.)	1.39	1.42	1.67	1.49	2.72

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	472.27
Total Operating Revenues	472.27
Other Income	6.10
Total Revenue	478.37
EXPENSES
Cost Of Materials Consumed	450.56
Purchase Of Stock-In Trade	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	3.94
Employee Benefit Expenses	0.76
Finance Costs	5.00
Depreciation And Amortisation Expenses	2.85
Other Expenses	9.83
Total Expenses	472.95
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	5.41
Profit/Loss Before Tax	5.41
Tax Expenses-Continued Operations
Current Tax	1.45
Deferred Tax	0.00
Tax For Earlier Years	0.00
Total Tax Expenses	1.45
Profit/Loss After Tax And Before ExtraOrdinary Items	3.97
Profit/Loss From Continuing Operations	3.97
Profit/Loss For The Period	3.97
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	1.39
Diluted EPS (Rs.)	1.39